(FPE3) Fuchs Petrolub SE - Ratings and Ratios
Lubricants, Greases, Metalworking Fluids, Process Oils, Fluids
FPE3 EPS (Earnings per Share)
FPE3 Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 24.5% |
| Value at Risk 5%th | 36.3% |
| Relative Tail Risk | -9.93% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.28 |
| Alpha | -17.58 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.557 |
| Beta | 0.323 |
| Beta Downside | 0.401 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.98% |
| Mean DD | 7.32% |
| Median DD | 5.40% |
Description: FPE3 Fuchs Petrolub SE November 05, 2025
Fuchs SE (formerly Fuchs Petrolub) manufactures and distributes a broad portfolio of lubricants and functional fluids across automotive, industrial, aerospace, wind-energy, and food sectors, ranging from biodegradable engine oils to metal-processing greases and specialty release agents. The company operates globally in Europe, the Middle East, Africa, Asia-Pacific, and the Americas, and its preference shares (XETRA:FPE3) give investors exposure to a diversified specialty-chemicals business with a long-standing brand dating back to 1931.
Key performance indicators (as of FY 2023) include revenue of roughly €2.0 billion, an adjusted EBITDA margin of ~13 %, and a free-cash-flow conversion above 80 %, supporting a dividend yield near 2.5 %. The lubricant market is projected to grow at a 4 % CAGR through 2028, driven by higher vehicle production, the shift toward electric-powertrain cooling fluids, and increasing demand for environmentally-friendly (biodegradable) products-factors that directly benefit Fuchs’s product mix. A material risk is the cyclical link between lubricant sales and global industrial output; a sustained slowdown in manufacturing or automotive shipments would pressure volumes and margins.
For a deeper quantitative assessment, you may want to explore Fuchs SE’s profile on ValueRay, where the platform aggregates recent analyst estimates and peer-adjusted valuation multiples.
FPE3 Stock Overview
| Market Cap in USD | 5,388m |
| Sub-Industry | Specialty Chemicals |
| IPO / Inception | |
| Return 12m vs S&P 500 | -21.8% |
| Analyst Rating | - |
FPE3 Dividends
| Dividend Yield | 3.00% |
| Yield on Cost 5y | 2.77% |
| Yield CAGR 5y | 3.43% |
| Payout Consistency | 88.1% |
| Payout Ratio | 51.9% |
FPE3 Growth Ratios
| CAGR 3y | 8.60% |
| CAGR/Max DD Calmar Ratio | 0.36 |
| CAGR/Mean DD Pain Ratio | 1.17 |
| Current Volume | 58.8k |
| Average Volume | 102.2k |
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (291.0m TTM) > 0 and > 6% of Revenue (6% = 213.9m TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA -1.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 18.57% (prev 19.52%; Δ -0.95pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.16 (>3.0%) and CFO 406.0m > Net Income 291.0m (YES >=105%, WARN >=100%) |
| Net Debt (59.0m) to EBITDA (533.0m) ratio: 0.11 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.00 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (131.0m) change vs 12m ago -0.23% (target <= -2.0% for YES) |
| Gross Margin 34.61% (prev 33.82%; Δ 0.79pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 140.1% (prev 139.9%; Δ 0.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 61.57 (EBITDA TTM 533.0m / Interest Expense TTM 7.00m) >= 6 (WARN >= 3) |
Altman Z'' 3.36
| (A) 0.25 = (Total Current Assets 1.32b - Total Current Liabilities 660.0m) / Total Assets 2.60b |
| (B) 0.06 = Retained Earnings (Balance) 144.0m / Total Assets 2.60b |
| (C) 0.17 = EBIT TTM 431.0m / Avg Total Assets 2.55b |
| (D) 0.35 = Book Value of Equity 275.0m / Total Liabilities 785.0m |
| Total Rating: 3.36 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.49
| 1. Piotroski 7.50pt = 2.50 |
| 2. FCF Yield 7.46% = 3.73 |
| 3. FCF Margin 9.85% = 2.46 |
| 4. Debt/Equity 0.11 = 2.49 |
| 5. Debt/Ebitda 0.11 = 2.49 |
| 6. ROIC - WACC (= 8.28)% = 10.36 |
| 7. RoE 15.60% = 1.30 |
| 8. Rev. Trend -7.05% = -0.53 |
| 9. EPS Trend 53.80% = 2.69 |
What is the price of FPE3 shares?
Over the past week, the price has changed by +0.36%, over one month by +0.72%, over three months by -4.79% and over the past year by -10.36%.
Is Fuchs Petrolub SE a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of FPE3 is around 35.87 EUR . This means that FPE3 is currently overvalued and has a potential downside of -7.98%.
Is FPE3 a buy, sell or hold?
What are the forecasts/targets for the FPE3 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 50.4 | 29.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 39.4 | 1.2% |
FPE3 Fundamental Data Overview January 01, 1970
Market Cap EUR = 4.65b (4.65b EUR * 1.0 EUR.EUR)
P/E Trailing = 17.4911
P/E Forward = 19.084
P/S = 1.3063
P/B = 2.7833
P/EG = 4.08
Beta = 0.825
Revenue TTM = 3.56b EUR
EBIT TTM = 431.0m EUR
EBITDA TTM = 533.0m EUR
Long Term Debt = 8.00m EUR (from longTermDebt, last quarter)
Short Term Debt = 146.0m EUR (from shortTermDebt, last quarter)
Debt = 193.0m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 59.0m EUR (from netDebt column, last quarter)
Enterprise Value = 4.71b EUR (4.65b + Debt 193.0m - CCE 134.0m)
Interest Coverage Ratio = 61.57 (Ebit TTM 431.0m / Interest Expense TTM 7.00m)
FCF Yield = 7.46% (FCF TTM 351.0m / Enterprise Value 4.71b)
FCF Margin = 9.85% (FCF TTM 351.0m / Revenue TTM 3.56b)
Net Margin = 8.16% (Net Income TTM 291.0m / Revenue TTM 3.56b)
Gross Margin = 34.61% ((Revenue TTM 3.56b - Cost of Revenue TTM 2.33b) / Revenue TTM)
Gross Margin QoQ = 35.11% (prev 34.31%)
Tobins Q-Ratio = 1.81 (Enterprise Value 4.71b / Total Assets 2.60b)
Interest Expense / Debt = 1.04% (Interest Expense 2.00m / Debt 193.0m)
Taxrate = 32.32% (32.0m / 99.0m)
NOPAT = 291.7m (EBIT 431.0m * (1 - 32.32%))
Current Ratio = 2.00 (Total Current Assets 1.32b / Total Current Liabilities 660.0m)
Debt / Equity = 0.11 (Debt 193.0m / totalStockholderEquity, last quarter 1.81b)
Debt / EBITDA = 0.11 (Net Debt 59.0m / EBITDA 533.0m)
Debt / FCF = 0.17 (Net Debt 59.0m / FCF TTM 351.0m)
Total Stockholder Equity = 1.87b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.19% (Net Income 291.0m / Total Assets 2.60b)
RoE = 15.60% (Net Income TTM 291.0m / Total Stockholder Equity 1.87b)
RoCE = 23.00% (EBIT 431.0m / Capital Employed (Equity 1.87b + L.T.Debt 8.00m))
RoIC = 15.23% (NOPAT 291.7m / Invested Capital 1.92b)
WACC = 6.94% (E(4.65b)/V(4.84b) * Re(7.20%) + D(193.0m)/V(4.84b) * Rd(1.04%) * (1-Tc(0.32)))
Discount Rate = 7.20% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -81.65 | Cagr: -0.78%
[DCF Debug] Terminal Value 80.80% ; FCFE base≈358.2m ; Y1≈422.3m ; Y5≈649.1m
Fair Price DCF = 169.9 (DCF Value 11.13b / Shares Outstanding 65.5m; 5y FCF grow 19.07% → 3.0% )
EPS Correlation: 53.80 | EPS CAGR: 14.08% | SUE: -1.02 | # QB: 0
Revenue Correlation: -7.05 | Revenue CAGR: -0.89% | SUE: 0.0 | # QB: 0